BiotechTube
Home/PentixaPharm/Henner Kollenberg
HK

Henner Kollenberg

CBO

PentixaPharm

Therapeutic Areas

OncologyCardiovascularEndocrine

PentixaPharm Pipeline

DrugIndicationPhase
PentixaForPrimary Aldosteronism (Diagnostic)Phase 3
PentixaTherHemato-oncology (e.g., Multiple Myeloma, Lymphoma)Phase 1/2

Leadership Team at PentixaPharm

DD
Dr. Dirk Pleimes
Group CEO & CMO
DE
Dr. Erik Merten
CTO
DA
Dr. Andreas Eckert
Chairman of the Supervisory Board
View full PentixaPharm profile